Correction to: Nature Communications https://doi.org/10.1038/s41467-022-32551-2, published online 22 August 2022
The original version of this article contained an error in the Abstract, which incorrectly omitted from the end the following: ‘Trial Registration: ClinicalTrials.gov Identifier: NCT04518410’. This has been corrected in both the PDF and HTML versions of the Article.
About this article
Cite this article
Chew, K.W., Moser, C., Daar, E.S. et al. Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19. Nat Commun 14, 333 (2023). https://doi.org/10.1038/s41467-023-35835-3